Healthcare
Afinum, SHS sell Evitria to trade
Exit values the Switzerland-based antibody expression specialist at more than EUR 200m
Capiton raises top-up single asset fund for KD Pharma
GP completed its first single-asset deal for KD Pharma in 2019, having acquired the company in 2013
Trilantic invests in Smile Eyes
Trilantic intends to pursue a buy-and-build strategy for the German ophthalmology clinic chain
GHO holds EUR 2bn final close for third fund
Fund close follows a fully virtual fundraise that saw the GP surpass its EUR 1.25bn target
EQT's Cerba buys Lifebrain from Investindustrial
Parties agreed on a price of more than EUR 1bn, with exclusivity awarded last week
Panakès Partners holds EUR 150m first close for second fund
Vehicle's target has been extended to EUR 180m and the fund will focus on medtech and biotech deals
Investindustrial's Lifebrain nears sale to Cerba HealthCare
Parties are in final-stage talks, with signing set to take place in the next couple of days
BC sells Pharmathen to Partners Group in EUR 1.6bn deal
BC Partners acquired the Greece-headquartered generic pharmaceuticals developer in 2015 for EUR 475m
WestBridge exits AJM Healthcare to Livingbridge
WestBridge backed the MBO of the wheelchair and mobility service provider in September 2018
Montagu acquires Intech from Eurazeo
Eurazeo says it is set to achieve a cash-on-cash multiple of 3x and an IRR of 31%
EQT sells Igenomix in €1.25bn trade sale
Igenomix had a €400m enterprise value at the time of EQT's initial investment in 2019
British Patient Capital launches £600m life sciences programme
Programme will invest in later-stage life sciences funds targeting at least £250m
Bridgepoint backs PharmaReview
GP is investing via its first Growth fund, which makes investments of up to £15m
Unigestion holds €611m final close for second Direct fund
Fund surpasses its €600m target and is more than 40% deployed
EQT to sell Fertin Pharma to Philip Morris
EQT exits the company four years after it acquired a 70% stake in it from the founding Bagger-Sørensen family
Carlyle injects €60m into Inova
GP invests via Carlyle Europe Technology Partners IV, a €1.4bn fund closed in 2019
Healthcare buyout value hits new high in first half
Trio of mega-buyouts push the aggregate value of deals to €19.5bn in H1, versus €11bn in H2 last year
Phoenix confirms Sygnature sale to Five Arrows
Deal is the third strong exit from Phoenix's 2016 fund, following Travel Chapter for 3.6x and Rayner for 4.3x
SoftBank leads $600m series-D for CMR Surgical
Series-D values the business at around $3bn, according to an FT report
ArchiMed buys Stragen Pharma
GP is investing via its €1bn Med Platform I, which backs healthcare firms with EVs of at least €100m
High-Tech Gründerfonds to launch fourth seed fund
Fund expects to launch its official fundraising process in September 2021, subject to BaFin approval
Healthcare valuations heat up as high-profile assets crystallise competition
Healthcare sector saw multiple valuations pick up in Q1 2021 and hit a record high of 13.7x
ABN Amro launches €425m Sustainable Impact Fund
Fund will make PE and VC investments in the Netherlands and neighbouring countries
Hannover Finanz buys majority stake in Dental Direkt
GP has acquired a 64% stake in the dental laboratory supplier as part of a succession solution
